Incorporation of Precursors into Ribonucleic Acid, Protein, Glycoprotein, and Lipoprotein of Avian Myeloblastosis Virions (original) (raw)

Abstract

Freshly explanted leukemic myeloblasts produce avian myeloblastosis virus (AMV) at a constant rate without any obvious cytopathic effect; therefore, subviral components are continually synthesized at a steady rate. The incorporation of various radioactive precursors into virions was monitored by determination of radioactivity in purified virus after density equilibrium sedimentation in preformed sucrose gradients. The kinetics of incorporation of 3H-uridine have shown that there is an average time interval of 3 to 4 hr (half-life) between the time viral ribo-nucleic acid (RNA) is synthesized and the time it is released as a mature virus particle; this represents the average time interval spent by AMV-RNA in an intracellular pool. Studies with 14C-phenylalanine have revealed that some protein synthesis takes place at or near the cell surface immediately prior to maturation and release of virus. 14C-glucosamine also appears to be incorporated into the outer viral envelope shortly before maturation. On the other hand, there is an average lag of about 16 to 20 hr before 14C-ethanolamine incorporated into intracellular lipoprotein appears in free virions; this probably reflects the kinetics of replacement of cellular surface membrane. Actinomycin D inhibits AMV-RNA within 30 min but permits the maturation of AMV to continue for at least 2 hr. AMV released in the presence of actinomycin D contains AMV-RNA synthesized before the addition of the drug.

554

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen D. W. Actinomycin D inhibition of avian myeloblastosis virus production by chick-embryo fibroblasts. Biochim Biophys Acta. 1966 Mar 21;114(3):606–611. doi: 10.1016/0005-2787(66)90108-0. [DOI] [PubMed] [Google Scholar]
  2. Allen D. W. Avian myeloblastosis virus (AMV) biosynthesis in chick embryo cells: studies of the particles released by trypsin from the infected cells. Virology. 1966 Sep;30(1):1–9. doi: 10.1016/s0042-6822(66)81003-6. [DOI] [PubMed] [Google Scholar]
  3. BADER J. P. THE REQUIREMENT FOR DNA SYNTHESIS IN THE GROWTH OF ROUS SARCOMA AND ROUS-ASSOCIATED VIRUSES. Virology. 1965 Jun;26:253–261. doi: 10.1016/0042-6822(65)90272-2. [DOI] [PubMed] [Google Scholar]
  4. BALUDA M. A., GOETZ I. E. Morphological conversion of cell cultures by avian myeloblastosis virus. Virology. 1961 Oct;15:185–199. doi: 10.1016/0042-6822(61)90234-3. [DOI] [PubMed] [Google Scholar]
  5. BEAUDREAU G. S., BECKER C., STIM T., WALLBANK A. M., BEARD J. W. Virus of avian myeloblastosis. XVI. Kinetics of cell growth and liberation of virus in cultures of myeloblasts. Natl Cancer Inst Monogr. 1960 Sep;4:167–187. [PubMed] [Google Scholar]
  6. BONAR R. A., BEARD J. W. Virus of avian myeloblastosis. XII. Chemical constitution. J Natl Cancer Inst. 1959 Jul;23(1):183–197. [PubMed] [Google Scholar]
  7. Biswal N., Grizzard M. B., McCombs R. M., Benyesh-Melnick M. Characterization of intracellular ribonucleic acid specific for the murine sarcoma-leukemia virus complex. J Virol. 1968 Nov;2(11):1346–1352. doi: 10.1128/jvi.2.11.1346-1352.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CRAWFORD L. V., CRAWFORD E. M. The properties of Rous sarcoma virus purified by density gradient centrifugation. Virology. 1961 Feb;13:227–232. doi: 10.1016/0042-6822(61)90056-3. [DOI] [PubMed] [Google Scholar]
  9. Dales S., Mosbach E. H. Vaccinia as a model for membrane biogenesis. Virology. 1968 Aug;35(4):564–583. doi: 10.1016/0042-6822(68)90286-9. [DOI] [PubMed] [Google Scholar]
  10. Duesberg P. H. Physical properties of Rous Sarcoma Virus RNA. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1511–1518. doi: 10.1073/pnas.60.4.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ECKERT E. A., BEARD D., BEARD J. W. Dose-response relations in experimental transmission of avian erythromyeoloblastic leukosis. V. Influence of host age and route of virus inoculation. J Natl Cancer Inst. 1955 Apr;15(5):1195–1207. [PubMed] [Google Scholar]
  12. Erikson R. L. Studies on the RNA from avian myeloblastosis virus. Virology. 1969 Jan;37(1):124–131. doi: 10.1016/0042-6822(69)90313-4. [DOI] [PubMed] [Google Scholar]
  13. Knudson A. G., Jr, Brodetsky A. M., Baluda M. A. Transient inhibition of avian myeloblastosis virus reproduction by amethopterin and fluorodeoxyuridine. J Virol. 1967 Dec;1(6):1150–1157. doi: 10.1128/jvi.1.6.1150-1157.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nayak D. P., Baluda M. A. An intermediate in the replication of influenza virus RNA. Proc Natl Acad Sci U S A. 1968 Jan;59(1):184–191. doi: 10.1073/pnas.59.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. PURCELL R. H., BONAR R. A., BEARD D., BEARD J. W. Virus of avian myeloblastosis. XX. Amino acid composition. J Natl Cancer Inst. 1962 Apr;28:1003–1011. [PubMed] [Google Scholar]
  16. Pastan I., Friedman R. M. Actinomycin D: inhibition of phospholipid synthesis in chick embryo cells. Science. 1968 Apr 19;160(3825):316–317. doi: 10.1126/science.160.3825.316. [DOI] [PubMed] [Google Scholar]
  17. Payne F. E., Solomon J. J., Purchase H. G. Immunofluorescent studies of group-specific antigen of the avian sarcoma-leukosis viruses. Proc Natl Acad Sci U S A. 1966 Feb;55(2):341–349. doi: 10.1073/pnas.55.2.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robinson W. S., Baluda M. A. The nucleic acid from avian myeloblastosis virus compared with the RNA from the Bryan strain of Rous sarcoma virus. Proc Natl Acad Sci U S A. 1965 Dec;54(6):1686–1692. doi: 10.1073/pnas.54.6.1686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. TEMIN H. M. THE EFFECTS OF ACTINOMYCIN D ON GROWTH OF ROUS SARCOMA VIRUS IN VITRO. Virology. 1963 Aug;20:577–582. doi: 10.1016/0042-6822(63)90282-4. [DOI] [PubMed] [Google Scholar]
  20. THEG D. E., BECKER C., BEARD J. W. VIRUS OF AVIAN MYELOBLASTOSIS (BAI STRAIN A). XXV. ULTRACYTOCHEMICAL STUDY OF VIRUS AND MYELOBLAST PHOSPHATASE ACTIVITY. J Natl Cancer Inst. 1964 Jan;32:201–235. [PubMed] [Google Scholar]
  21. VIGIER P., GOLDE A. EFFECTS OF ACTINOMYCIN D AND OF MITOMYCIN C ON THE DEVELOPMENT OF ROUS SARCOMA VIRUS. Virology. 1964 Aug;23:511–519. doi: 10.1016/0042-6822(64)90235-1. [DOI] [PubMed] [Google Scholar]
  22. VOGT P. K., RUBIN H. Studies on the assay and multiplication of avian myeloblastosis virus. Virology. 1963 Jan;19:92–104. doi: 10.1016/0042-6822(63)90029-1. [DOI] [PubMed] [Google Scholar]
  23. Vaughan M. H., Warner J. R., Darnell J. E. Ribosomal precursor particles in the HeLa cell nucleus. J Mol Biol. 1967 Apr 28;25(2):235–251. doi: 10.1016/0022-2836(67)90140-4. [DOI] [PubMed] [Google Scholar]
  24. Vogt P. K. Avian tumor viruses. Adv Virus Res. 1965;11:293–385. doi: 10.1016/s0065-3527(08)60549-7. [DOI] [PubMed] [Google Scholar]